Table 4.

Levels of phenotypic antigen expression in healthy subjects and tumor patients

	HS	Men	Women	TP	Men	Women
CD3	59.8 ± 1.3	60.9 ± 1.8	58.3 ± 1.9	49.0 ± 2.3	46.7 ± 2.8	52.4 ± 4.0
CD8	25.3 ± 0.9	25.0 ± 1.3	26.1 ± 1.2	20.0 ± 1.3	19.2 ± 1.5	21.4 ± 2.3
CD16	12.5 ± 1.1	16.5 ± 1.8	7.7 ± 0.8	15.5 ± 1.3	15.4 ± 1.5	14.7 ± 2.3
CD56	11.8 ± 1.2	14.6 ± 1.9	8.5 ± 0.9	16.4 ± 1.6	17.5 ± 2.0	14.9 ± 2.5
CD57	23.7 ± 1.2	25.9 ± 1.8	21.5 ± 1.3	23.7 ± 1.8	22.3 ± 1.8	26.2 ± 4.0
CD3-CD56+	19.7 ± 0.1	19.7 ± 0.1	19.7 ± 0.1	12.7 ± 3.2	18.0 ± 5.5	7.3 ± 2.1
CD8-CD57+	11.4 ± 1.6	12.4 ± 2.0	8.4 ± 2.2	7.2 ± 3.1	15.5 ± 0.1	4.5 ± 1.9